Marsdenoside ICAS# 872993-75-4 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
| Cas No. | 872993-75-4 | SDF | Download SDF |
| PubChem ID | N/A | Appearance | Powder |
| Formula | C35H56O12 | M.Wt | 668.91 |
| Type of Compound | Steroids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Marsdenoside I Dilution Calculator
Marsdenoside I Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.495 mL | 7.4748 mL | 14.9497 mL | 29.8994 mL | 37.3742 mL |
| 5 mM | 0.299 mL | 1.495 mL | 2.9899 mL | 5.9799 mL | 7.4748 mL |
| 10 mM | 0.1495 mL | 0.7475 mL | 1.495 mL | 2.9899 mL | 3.7374 mL |
| 50 mM | 0.0299 mL | 0.1495 mL | 0.299 mL | 0.598 mL | 0.7475 mL |
| 100 mM | 0.0149 mL | 0.0747 mL | 0.1495 mL | 0.299 mL | 0.3737 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- (E)-Eucomin
Catalog No.:BCX0267
CAS No.:17934-08-6
- Isogarcinol
Catalog No.:BCX0266
CAS No.:71117-97-0
- Suffruticosol D
Catalog No.:BCX0265
CAS No.:1261292-11-8
- N-(3-(4-Fluorophenyl)propyl)-7-hydroxycoumarin-3-carboxamide
Catalog No.:BCX0264
CAS No.:2136579-33-2
- Assiguxanthone B
Catalog No.:BCX0263
CAS No.:197447-29-3
- Pruniflorone R
Catalog No.:BCX0262
CAS No.:1238102-65-2
- (2S,3S)-Pterosin S 14-O-glucoside
Catalog No.:BCX0261
CAS No.:62043-50-9
- Sanggenon O
Catalog No.:BCX0260
CAS No.:101664-32-8
- Sibiriquinone B
Catalog No.:BCX0259
CAS No.:723300-09-2
- Suffruticosol B
Catalog No.:BCX0258
CAS No.:220936-87-8
- Arucadiol
Catalog No.:BCX0257
CAS No.:105037-85-2
- (E)-α-Atlantone
Catalog No.:BCX0256
CAS No.:26294-59-7
- Daphnetin 8-O-glucoside
Catalog No.:BCX0269
CAS No.:20853-56-9
- Euryanoside
Catalog No.:BCX0270
CAS No.:125300-52-9
- Suffruticosol A
Catalog No.:BCX0271
CAS No.:220936-82-3
- 6α-Hydroxystigmast-4-en-3-one
Catalog No.:BCX0272
CAS No.:75686-40-7
- Kushenol Q
Catalog No.:BCX0273
CAS No.:952491-35-9
- Suffruticosol C
Catalog No.:BCX0274
CAS No.:220936-94-7
- 6-(4-Hydroxyphenyl)-2-methylhept-2-en-4-one
Catalog No.:BCX0275
CAS No.:949081-06-5
- Lup-20(29)-ene-2α,3α-diol
Catalog No.:BCX0276
CAS No.:55476-83-0
- Trijugin C
Catalog No.:BCX0277
CAS No.:1233534-45-6
- Aromadendrin 6-C-glucoside
Catalog No.:BCX0278
CAS No.:112494-34-5
- Pteroside T
Catalog No.:BCX0279
CAS No.:62043-51-0
- Taxifolin 6-C-glucoside
Catalog No.:BCX0280
CAS No.:112494-39-0
Simultaneous determination of six C21 steroids of Xiao-Ai-Ping injection in rat plasma by LC-MS/MS.[Pubmed:24037806]
Biomed Chromatogr. 2014 Feb;28(2):223-30.
Xiao-Ai-Ping injection (XAPI) is a traditional Chinese medicine that has been widely used to treat cancer. Modern pharmacological studies have demonstrated that C21 steroids are the main active compounds in XAPI. In this study, a sensitive and specific liquid chromatography tandem mass spectrometry (LC-MS/MS) method was developed and validated the first time for simultanenous determination of three isomeric pregnane genins (17beta-tenacigenin B, tenacigenin B and tenacigenin A) and their corresponding glycosides (tenacigenoside A, tenacissoside F and Marsdenoside I) from XAPI in rat plasma. A simple liquid-liquid extraction technique was used after the addition of dexamethasone acetate as internal standard. The chromatography separation of analytes was achieved on an Agilent Zorbax Eclipse XDB-C18 column (3.5 microm, 150 x 3 mm i.d.) using methanol-water as mobile phase in a gradient elution program. Detection was performed in multiple reaction monitoring mode using electrospray ionization in the negative ion mode. The method showed satisfactory linearity over a concentration range 5.00-2000.00 ng/mL for tenacigenin B, tenacigenin A, Marsdenoside I and tenacissoside F (r(2) > 0.99), 10.00-4000.00 ng/mL for 17beta-tenacigenin B and tenacigenoside A (r(2) > 0.99). Intra- and inter-day precisions (valued as relative standard deviation) were <9.00% and accuracies (as relative error) in the range -6.31 to 7.23%. Finally, this validated method was successfully applied to the pharmacokinetic study of XAPI after intravenous administration to rats.
